---
title: "PepGen Files $400 Million Mixed Shelf"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286946645.md"
description: "12:23 PM EDT, 05/19/2026 (MT Newswires) -- PepGen ( PEPG ) filed a registration statement Monday for the potential sale of up to $400 million of securities from time to time.The filing covers common and preferred stocks, debt securities, warrants, and units.Net proceeds will be used for general corporate purposes, the company said.Price: 1.41, Change: -0.06, Percent Change: -4.08 MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited."
datetime: "2026-05-19T16:23:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286946645.md)
  - [en](https://longbridge.com/en/news/286946645.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286946645.md)
---

# PepGen Files $400 Million Mixed Shelf

12:23 PM EDT, 05/19/2026 (MT Newswires) -- PepGen ( PEPG ) filed a registration statement Monday for the potential sale of up to $400 million of securities from time to time.

The filing covers common and preferred stocks, debt securities, warrants, and units.

Net proceeds will be used for general corporate purposes, the company said.

Price: 1.41, Change: -0.06, Percent Change: -4.08

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [PEPG.US](https://longbridge.com/en/quote/PEPG.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)

## Related News & Research

- [Korro Bio To Advance KRRO-111 As Potential Treatment For AATD](https://longbridge.com/en/news/287089978.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)
- [Roivant posts unexpected Q4 profit due to Moderna lawsuit settlement gain](https://longbridge.com/en/news/287053604.md)
- [Candel Therapeutics Reports Positive Phase 3 Prostate Cancer Trial Data](https://longbridge.com/en/news/286652611.md)
- [MiNK Therapeutics' Q1 net loss narrows slightly](https://longbridge.com/en/news/286558132.md)